Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL-Reference-Cited by-同舟云学术

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL

Published:2016-02 Issue:2 Volume:27 Page:286-294
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Graff J.N.,Baciarello G.,Armstrong A.J.,Higano C.S.,Iversen P.,Flaig T.W.,Forer D.,Parli T.,Phung D.,Tombal B.,Beer T.M.,Sternberg C.N.

Funder

Medivation, Inc.

Astellas Pharma Global Development, Inc.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/2/286/16699631/mdv542.pdf

Reference25 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality;Scosyrev;Cancer,2012

3. U.S. decennial life tables for 1999–2001, United States life tables;Arias;Natl Vital Stat Rep,2008

4. Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study;de Camargo Cancela;Br J Cancer,2013

5. Population-based study on use of chemotherapy in men with castration resistant prostate cancer;Lissbrant;Acta Oncol,2013

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study;Clinical Genitourinary Cancer;2024-08

2. Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm;Clinical Genitourinary Cancer;2024-08

3. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies;ESMO Open;2024-07

4. Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost—a survey in Japan;Japanese Journal of Clinical Oncology;2024-06-07

5. Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy;Drug Safety;2024-04-12